This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep 10;24(14):2298-9; author reply 2299-300.

doi: 10.1097/QAD.0b013e32833d4364.

Ethics and the standards of prevention in HIV prevention trials

Jeremy Sugarman, William C Grace

PMID: 20736687
DOI: 10.1097/QAD.0b013e32833d4364

Comment

Ethics and the standards of prevention in HIV prevention trials

Jeremy Sugarman et al. AIDS. 2010.

. 2010 Sep 10;24(14):2298-9; author reply 2299-300.

doi: 10.1097/QAD.0b013e32833d4364.

Authors

Jeremy Sugarman, William C Grace

PMID: 20736687
DOI: 10.1097/QAD.0b013e32833d4364

No abstract available

PubMed Disclaimer

Comment on

Weighing the gold in the gold standard: challenges in HIV prevention research.
Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Padian NS, et al. AIDS. 2010 Mar 13;24(5):621-35. doi: 10.1097/QAD.0b013e328337798a. AIDS. 2010. PMID: 20179575 Free PMC article.

Similar articles

Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
Snyder J, Miller CL, Gray G. Snyder J, et al. Am J Bioeth. 2011 Jun;11(6):W1-3. doi: 10.1080/15265161.2011.578477. Am J Bioeth. 2011. PMID: 21678202 No abstract available.
Uniqueness, exploitation, and relative risk standards in adolescent research.
Malek J. Malek J. Am J Bioeth. 2011 Jun;11(6):23-5. doi: 10.1080/15265161.2011.568587. Am J Bioeth. 2011. PMID: 21678211 No abstract available.
Back to the rough ground: working in international HIV prevention as ethical debates continue.
MacQueen KM, Sugarman J. MacQueen KM, et al. IRB. 2003 Mar-Apr;25(2):11-3. IRB. 2003. PMID: 12833902 No abstract available.
Creating effective partnerships for HIV prevention trials: report of a UNAIDS Consultation, Geneva 20-21 June 2005.
UNAIDS. UNAIDS. AIDS. 2006 Apr 4;20(6):W1-11. doi: 10.1097/01.aids.0000218573.29930.67. AIDS. 2006. PMID: 16549961
Sexually transmitted disease prevention approaches that work. Interventions to reduce risk behavior among individuals, groups, and communities.
Kelly JA. Kelly JA. Sex Transm Dis. 1994 Mar-Apr;21(2 Suppl):S73-5. Sex Transm Dis. 1994. PMID: 8042122 Review.

See all similar articles

Cited by

The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials.
Ross E, Tanser F, Pei P, Newell ML, Losina E, Thiebaut R, Weinstein M, Freedberg K, Anglaret X, Scott C, Dabis F, Walensky R. Ross E, et al. HIV Clin Trials. 2014 Sep-Oct;15(5):185-98. doi: 10.1310/hct1505-185. HIV Clin Trials. 2014. PMID: 25350957 Free PMC article.
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.
Moorhouse R, Slack C, Quayle M, Essack Z, Lindegger G. Moorhouse R, et al. BMC Med Ethics. 2014 Jun 30;15:51. doi: 10.1186/1472-6939-15-51. BMC Med Ethics. 2014. PMID: 24981027 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

U01AI068619/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information